NDAOPHTHALMICSUSPENSION/DROPSPriority Review
Approved
Feb 2000
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Clinical Trials (1)
Safety and Efficacy Study of BETAXON 0.5% and AZOPT 1.0% in Pediatric Patients With Glaucoma or Ocular Hypertension
Started Jan 2003
78 enrolled
GlaucomaOcular Hypertension
Company
Alcon
FORT WORTH, TX
External Resources